This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The World Market For Stents (Drug-Eluting And Bare Metal Product Markets In US, EU, Japan, India, China And ROW)

Table 3-1: Selected Marketed Bare Metal Stents, 2012


Table 3-2: Selected Bare Metal Coronary Stents, 2012


Table 3-3: Selected Marketed Drug-Eluting Stents, 2012


Table 3-4: Selected Features of Different Generations of Commercially


Available Drug-eluting Stents






Table 4-1: Selected Coronary Stents using Biodegradable Polymers, 2012


Table 4-2: Selected Coronary Polymer-free and Novel Coating Stents, 2012


Table 4-3: Selected Direct Drug Application Coronary Stents, 2012


Table 4-4: Selected Coronary Polymer and Drug-free Coating Stents, 2012


Table 4-5: Advantages and Disadvantages of Bioresorbable Stents


Table 4-6: Selected Bioresorbable Coronary Stents, 2012


Table 4-7: Selected Dedicated Bifurcation Coronary Drug-Eluting Stents, 2012


Table 4-8: Selected Dedicated Small Vessels Coronary Drug-Eluting Stents, 2012


Table 4-9: Drug Release Parameters of Selected Drug-Eluting Stents




Table 5-1: Industry Structure – Major Competitors and Selected


Marketed Products, 2012


Table 5-2: Significant Trends in the Coronary Stents Market, 2012




Table 6-1: Coronary Stents Estimated Global Market Shares, 2011


Figure 6-1: Stents Market Share, 2011


Table 6-2: Global Market Revenues for Coronary Stents ($ Millions)


Figure 6-2: Global Stents Market Forecast


Figure 6-3: Market Breakdown by Type of Stent (BMS, DES)


Figure 6-4: Drug Eluting Stents Market Shre, 2011


Table 6-3: Global Market Revenues for Coronary Stents ($ Millions)


Figure 6-5: Global Market Revenues Forecast ($ Billions)Drug-Eluting Stents, 2010-2017


Figure 6-6: Market Breakdown by Type of Stent (BMS, DES)


Figure 6-7: Market Share Bare Metal Stents


Table 6-4: Global Market Revenues for Coronary Bare Metal Stents, 2010-2017 (Bare Metal Stent, Drug Eluding Stent, Total)


Figure 6-8: Bare Metal Stents Market 2010-2017

5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs